[Lamprène. New therapeutic indications (excluding leprosy)].
D000152:Acne Vulgaris / Q000188:drug therapy; D000328:Adult; D002991:Clofazimine / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008179:Lupus Erythematosus, Discoid / Q000188:drug therapy; D008177:Lupus Vulgaris / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D011711:Pyoderma / Q000188:drug therapy; D012871:Skin Diseases / Q000188:drug therapy*; D012883:Skin Ulcer / Q000188:drug therapy; D014820:Vitiligo / Q000188:drug therapy
D002991:Clofazimine
Le Lamprène. Indications thérapeutiques nouvelles (lèpre exclue).